1.14000 USD
0.024
2.06%
Last update Dec 16, 3:57 PM EST
Market closed
Day range
1.14000
1.18000
Previous close
1.16400
Open
1.18000
Access this stock data via API
Subscribe
Interpace Biosciences Inc.
1.14
0.02
2.06%

Financials

Income statement

Fiscal date 2024 2023 2022 2021
Total reported revenue 46.9M 40.2M 31.8M 33.1M
Cost of revenue 17.0M 16.3M 13.6M 14.3M
Gross profit 29.9M 23.9M 18.2M 18.8M
Operating expense
Research & development 676K 636K 703K 1.5M
Selling general and admin 21.1M 19.6M 20.1M 19.9M
Other operating expenses
Operating income 8.1M 2.8M -3.8M -5.8M
Non operating interest income
Income
Expense 659K 1.0M 1.0M 1.0M
Other income expense -499K -674K -988K -938K
Pretax income 7.0M 1.1M -5.8M -7.7M
Tax provision 4K 17K 29K -705K
Net income 6.7M 802K -22.0M -14.9M
Basic EPS 1.4 0.2 -5.2 -3.6
Diluted EPS 0.4 0.2 -5.2 -3.6
Basic average shares 4.4M 4.3M 4.2M 4.1M
Diluted average shares 4.4M 4.3M 4.2M 4.1M
EBITDA 8.4M 3.7M -1.5M -769K
Net income from continuing op. 6.7M 802K -22.0M -14.9M
Minority interests
Preferred stock dividends 0
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Market closed

Exchange is currently closed
Pre-market opens in 7 hours 24 minutes

22:35
00:00
09:30
16:00
23:59

Trading Hours (Monday - Friday):

Pre-market
06:00 - 09:30
Main market
09:30 - 16:00
Post-market
16:00 - 17:00
All times are displayed in the America/New_York timezone (EST, UTC-05:00).